Evaluation of MIG-SPRAY Treatment on Migraine

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

September 15, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Migraine
Interventions
COMBINATION_PRODUCT

MIG-SPRAY

"MIG-SPRAY® is a film-forming liquid dressing designed for the preventive treatment of migraine.~Key Features:~* Administration:~ * Applied as 2 sprays per nostril, 3 times daily.~ * Treatment duration: 3 months.~* Mechanism: Forms a protective film on the nasal mucosa, potentially modulating local triggers of migraine.~* Use Case: Prophylactic (preventive) therapy for migraine, intended to reduce attack frequency and severity.~Additional Notes:~* Non-systemic (local action).~* CE-marked as a Class I medical device (under EU Directive 93/42/EEC)."

Trial Locations (1)

63000

CHU de Clermont-ferrand, Clermont-Ferrand

All Listed Sponsors
lead

University Hospital, Clermont-Ferrand

OTHER